{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:27:58Z","timestamp":1782930478860,"version":"3.54.5"},"reference-count":79,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T00:00:00Z","timestamp":1527120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Carbonic anhydrases (CAs) are a superfamily of metalloenzymes widespread in all life, classified into seven genetically different families (\u03b1\u2013\u03b8). These enzymes catalyse the reversible hydration of carbonic anhydride (CO2), generating bicarbonate (HCO3\u2212) and protons (H+). Fifteen isoforms of human CA (hCA I\u2013XV) have been isolated, their presence being fundamental for the regulation of many physiological processes. In addition, overexpression of some isoforms has been associated with the outbreak or progression of several diseases. For this reason, for a long time CA inhibitors (CAIs) have been used in the control of glaucoma and as diuretics. Furthermore, the search for new potential CAIs for other pharmacological applications is a very active field. Amino acids constitute the smallest fundamental monomers of protein and, due to their useful bivalent chemical properties, are widely used in organic chemistry. Both proteinogenic and non-proteinogenic amino acids have been extensively used to synthesize CAIs. This article provides an overview of the different strategies that have been used to design new CAIs containing amino acids, and how these bivalent molecules influence the properties of the inhibitors.<\/jats:p>","DOI":"10.3390\/metabo8020036","type":"journal-article","created":{"date-parts":[[2018,5,28]],"date-time":"2018-05-28T03:54:21Z","timestamp":1527479661000},"page":"36","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Amino Acids as Building Blocks for Carbonic Anhydrase Inhibitors"],"prefix":"10.3390","volume":"8","author":[{"given":"Niccol\u00f2","family":"Chiaramonte","sequence":"first","affiliation":[{"name":"Department of Neuroscience, Psychology, Drug Research and Child\u2019s Health, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5685-3403","authenticated-orcid":false,"given":"Maria Novella","family":"Romanelli","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Psychology, Drug Research and Child\u2019s Health, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Teodori","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Psychology, Drug Research and Child\u2019s Health, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Psychology, Drug Research and Child\u2019s Health, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,5,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11099-017-0685-4","article-title":"Carbonic anhydrase\u2014A universal enzyme of the carbon-based life","volume":"55","author":"Kupriyanova","year":"2017","journal-title":"Photosynthetica"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem. J."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Supuran, C.T., and De Simone, G. (2015). Carbonic Anhydrases: An Overview. Carbonic Anhydrases as Biocatalysts: From Theory to Medical and Industrial Applications, Elsevier.","DOI":"10.1016\/B978-0-444-63258-6.00001-9"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"D\u2019Ambrosio, K., De Simone, G., and Supuran, C.T. (2015). Human Carbonic Anhydrases: Catalytic Properties, Structural Features, and Tissue Distribution. Carbonic Anhydrases as Biocatalysts: From Theory to Medical and Industrial Applications, Elsevier.","DOI":"10.1016\/B978-0-444-63258-6.00002-0"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Supuran, C. (2018). Carbonic Anhydrases and Metabolism. Metabolites, 8.","DOI":"10.3390\/metabo8020025"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"15184","DOI":"10.1073\/pnas.96.26.15184","article-title":"Carbonic anhydrase is an ancient enzyme widespread in prokaryotes","volume":"96","author":"Smith","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The Carbon Dioxide Hydration Activity of Carbonic Anhydrase","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(96)00198-2","article-title":"Structure and mechanism of carbonic anhydrase","volume":"74","author":"Lindskog","year":"1997","journal-title":"Pharmacol. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1021\/ar00145a005","article-title":"The Catalytic Mechanism of Carbonic Anhydrase: Implications of a Rate-Limiting Protolysis of Water","volume":"21","author":"Silverman","year":"1988","journal-title":"Acc. Chem. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: How to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1517\/13543776.2013.794788","article-title":"Antiglaucoma carbonic anhydrase inhibitors: A patent review","volume":"23","author":"Masini","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Supuran, C.T. (2017). Carbonic anhydrase inhibition and the management of hypoxic tumors. Metabolites, 7.","DOI":"10.3390\/metabo7030048"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Singh, S., Lomelino, C.L., Mboge, M.Y., and Frost, S.C. (2018). Cancer Drug Development of Carbonic Anhydrase Inhibitors beyond the Active Site. Molecules, 23.","DOI":"10.3390\/molecules23051045"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Mboge, M., Mahon, B., McKenna, R., and Frost, S. (2018). Carbonic Anhydrases: Role in pH Control and Cancer. Metabolites, 8.","DOI":"10.3390\/metabo8010019"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4155\/fmc-2017-0223","article-title":"Carbonic anhydrase activators","volume":"10","author":"Supuran","year":"2018","journal-title":"Future Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1517\/13543776.2013.780598","article-title":"Diuretics with carbonic anhydrase inhibitory action: A patent and literature review (2005\u20132013)","volume":"23","author":"Carta","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1517\/13543776.2013.798648","article-title":"Anticancer carbonic anhydrase inhibitors: A patent review (2008\u20132013)","volume":"23","author":"Monti","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1517\/13543776.2013.790957","article-title":"Antiobesity carbonic anhydrase inhibitors: A literature and patent review","volume":"23","author":"Scozzafava","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/17460441.2017.1253677","article-title":"Advances in structure-based drug discovery of carbonic anhydrase inhibitors","volume":"12","author":"Supuran","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1517\/17460441.2013.795145","article-title":"Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors","volume":"8","author":"Alterio","year":"2013","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ejmech.2018.04.002","article-title":"2-Benzylpiperazine: A new scaffold for potent human carbonic anhydrase inhibitors. Synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies and in vivo activity for a new class of intraocular pressure lowering agents","volume":"151","author":"Chiaramonte","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/14756366.2012.672983","article-title":"Structure-based drug discovery of carbonic anhydrase inhibitors","volume":"27","author":"Supuran","year":"2012","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Karioti, A., Carta, F., and Supuran, C.T. (2016). Phenols and polyphenols as Carbonic anhydrase inhibitors. Molecules, 21.","DOI":"10.3390\/molecules21121649"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1021\/jm901287j","article-title":"Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins","volume":"53","author":"Maresca","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1039\/C4CC07320G","article-title":"Out of the active site binding pocket for carbonic anhydrase inhibitors","volume":"51","author":"Carradori","year":"2015","journal-title":"Chem. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.jprot.2012.01.041","article-title":"Amino acids: Chemistry, functionality and selected non-enzymatic post-translational modifications","volume":"75","author":"Bischoff","year":"2012","journal-title":"J. Proteomics"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00726-017-2516-0","article-title":"Thirteen decades of peptide synthesis: Key developments in solid phase peptide synthesis and amide bond formation utilized in peptide ligation","volume":"50","author":"Jaradat","year":"2018","journal-title":"Amino Acids"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/jop.2014.0067","article-title":"Pharmacotherapy of Glaucoma","volume":"31","author":"Schmidl","year":"2015","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1350-9462(99)00006-3","article-title":"Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors","volume":"19","author":"Sugrue","year":"2000","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Supuran, C.T., Casini, A., and Scozzafava, A. (2004). Development of Sulfonamide Carbonic Anhydrase Inhibitors. Carbonic Anhydrase, CRC Press.","DOI":"10.4324\/9780203475300"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1152\/physrev.1967.47.4.595","article-title":"Carbonic anhydrase: Chemistry, physiology, and inhibition","volume":"47","author":"Maren","year":"1967","journal-title":"Physiol. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1021\/jm001051+","article-title":"Carbonic anhydrase inhibitors: Water-soluble 4-sulfamoylphenylthioureas as topical intraocular pressure-lowering agents with long-lasting effects","volume":"43","author":"Casini","year":"2000","journal-title":"J. Med. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1021\/jm9901879","article-title":"Carbonic anhydrase inhibitors: Synthesis of water-soluble, aminoacyl\/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route","volume":"42","author":"Scozzafava","year":"1999","journal-title":"J. Med. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1021\/jm00092a021","article-title":"Acetazolamide-like Carbonic Anhydrase Inhibitors with Topical Ocular Hypotensive Activity","volume":"35","author":"Antonaroli","year":"1992","journal-title":"J. Med. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0960-894X(00)80266-8","article-title":"Synthesis of 2-substituted-1,3,4-thiadiazole-5-sulphonamides as novel water-soluble inhibitors of carbonic anhydrase","volume":"1","author":"Jayaweera","year":"1991","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/14756369909030339","article-title":"Carbonic anhydrase inhibitors. Synthesis of topically effective intraocular pressure lowering agents derived from 5-(omega-aminoalkylcarboxamido)-1,3,4-thiadiazole-2-sulfonamide","volume":"15","author":"Barboiu","year":"1999","journal-title":"J. Enzym. Inhib."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0223-5234(00)00130-6","article-title":"Carbonic anhydrase inhibitors\u2014Part 78. Synthesis of water-soluble sulfonamides incorporating \u03b2-alanyl moieties, possessing long lasting- intraocular pressure lowering properties via the topical route","volume":"35","author":"Supuran","year":"2000","journal-title":"Eur. J. Med. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-4835(92)90094-9","article-title":"Relations among IOP reduction, ocular disposition and pharmacology of the carbonic anhydrase inhibitor ethoxzolamide","volume":"55","author":"Maren","year":"1992","journal-title":"Exp. Eye Res."},{"key":"ref_42","first-page":"2581","article-title":"pH and drug ionization affects ocular pressure lowering of topical carbonic anhydrase inhibitors","volume":"34","author":"Brechue","year":"1993","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1016\/j.bmcl.2014.06.024","article-title":"Synthesis of sulfonamides with effective inhibitory action against Porphyromonas gingivalis \u03b3-carbonic anhydrase","volume":"24","author":"Ceruso","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/14756366.2014.942659","article-title":"New series of sulfonamides containing amino acid moiety act as effective and selective inhibitors of tumor-associated carbonic anhydrase XII","volume":"30","author":"Ceruso","year":"2015","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/1475636021000010950","article-title":"Carbonic anhydrase inhibitors: Synthesis of water soluble sulfonamides incorporating a 4-sulfamoylphenylmethylthiourea scaffold, with potent intraocular pressure lowering properties","volume":"17","author":"Casin","year":"2002","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S0960-894X(01)00303-1","article-title":"Carbonic anhydrase inhibitors: 4-Sulfamoyl-benzenecarboxamides and 4-chloro-3-sulfamoyl-benzenecarboxamides with strong topical antiglaucoma properties","volume":"11","author":"Mincione","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1021\/jm00013a004","article-title":"Secondary Interactions Significantly Removed from the Sulfonamide Binding Pocket of Carbonic Anhydrase II Influence Inhibitor Binding Constants","volume":"38","author":"Boriack","year":"1995","journal-title":"J. Med. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1021\/ja00091a005","article-title":"Lack of Effect of the Length of Oligoglycine- and Oligo(ethylene glycol)-Derived para-Substituents on the Affinity of Benzenesulfonamides for Carbonic Anhydrase II in Solution","volume":"116","author":"Jain","year":"1994","journal-title":"J. Am. Chem. Soc."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1021\/jm00039a023","article-title":"Identification of Two Hydrophobic Patches in the Active-Site Cavity of Human Carbonic Anhydrase II by Solution-Phase and Solid-State Studies and Their Use in the Development of Tight-Binding Inhibitors","volume":"37","author":"Jain","year":"1994","journal-title":"J. Med. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1016\/j.bmcl.2005.04.056","article-title":"Carbonic anhydrase inhibitors: Novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX","volume":"15","author":"Garaj","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1016\/j.bmc.2011.04.005","article-title":"Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies","volume":"19","author":"Carta","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1016\/j.bmc.2010.03.026","article-title":"Nanoscale enzyme inhibitors: Fullerenes inhibit carbonic anhydrase by occluding the active site entrance","volume":"18","author":"Innocenti","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"ref_53","first-page":"41","article-title":"The antiretroviral agent Fullevir","volume":"54","author":"Nosik","year":"2009","journal-title":"Vopr. Virusol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1021\/ja00068a006","article-title":"Synthesis of a Fullerene Derivative for the Inhibition of HIV Enzymes","volume":"115","author":"Sijbesma","year":"1993","journal-title":"J. Am. Chem. Soc."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/smll.200801820","article-title":"Cancer-cell targeting and photoacoustic therapy using carbon nanotubes as \u201cbomb\u201d agents","volume":"5","author":"Kang","year":"2009","journal-title":"Small"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1016\/j.bmcl.2009.08.067","article-title":"Antioxidant action of sugar-pendant C60 fullerenes","volume":"19","author":"Horie","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1021\/nn900318y","article-title":"Fullerenol-cytotoxic conjugates for cancer chemotherapy","volume":"3","author":"Chaudhuri","year":"2009","journal-title":"ACS Nano"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Alterio, V., Di Flore, A., D\u2019Ambrosio, K., Supuran, C.T., and De Simone, G. (2009). X-ray Crystallography of Carbonic Anhydrase Inhibitors and Its Importance in Drug Design, Wiley.","DOI":"10.1002\/9780470508169.ch4"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.3109\/14756366.2016.1147438","article-title":"Synthesis and carbonic anhydrase I, II, IV and XII inhibitory properties of N-protected amino acid-sulfonamide conjugates","volume":"31","author":"Tanc","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3109\/14756366.2015.1113173","article-title":"Synthesis and carbonic anhydrase inhibitory properties of amino acid\u2013coumarin\/quinolinone conjugates incorporating glycine, alanine and phenylalanine moieties","volume":"31","author":"Tanc","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3109\/14756366.2015.1114931","article-title":"Synthesis, characterization and carbonic anhydrase inhibitory activity of novel benzothiazole derivatives","volume":"31","author":"Tanc","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Lomelino, C.L., Supuran, C.T., and McKenna, R. (2016). Non-classical inhibition of carbonic anhydrase. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17071150"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10593-015-1748-8","article-title":"In a search for selective inhibitors of carbonic anhydrases: Coumarin and its bioisosteres\u2014Synthesis and derivatization","volume":"51","year":"2015","journal-title":"Chem. Heterocycl. Compd."},{"key":"ref_64","unstructured":"Kolb, H.C., Walsh, J.C., Kasi, D., Mocharla, V., Wang, B., Gangadharmath, U.B., Duclos, B.A., Chen, K., Zhang, W., and Chen, G. (2008). Development of Triazole Derivatives as Molecular Imaging Probes for Carbonic Anhydrase-IX Using Click Chemistry. (EP20080745260), PCT International Application, 188p."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s11307-015-0831-y","article-title":"[18F]VM4-037 MicroPET Imaging and Biodistribution of Two In Vivo CAIX-Expressing Tumor Models","volume":"17","author":"Peeters","year":"2015","journal-title":"Mol. Imaging Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s11307-014-0730-7","article-title":"Biodistribution and radiation dosimetry of the carbonic anhydrase IX imaging agent [18F]VM4-037 determined from PET\/CT scans in healthy volunteers","volume":"16","author":"Doss","year":"2014","journal-title":"Mol. Imaging Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"17356","DOI":"10.3390\/molecules191117356","article-title":"4-Amino-substituted Benzenesulfonamides as Inhibitors of Human Carbonic Anhydrases","volume":"19","author":"Rutkauskas","year":"2014","journal-title":"Molecules"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bioorg.2017.08.017","article-title":"N-Sulfamoylphenyl- and N-sulfamoylphenyl-N-thiazolyl-\u03b2-alanines and their derivatives as inhibitors of human carbonic anhydrases","volume":"75","author":"Matulis","year":"2017","journal-title":"Bioorg. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"6768","DOI":"10.1016\/j.bmc.2014.10.041","article-title":"Inhibition studies of new ureido-substituted sulfonamides incorporating a GABA moiety against human carbonic anhydrase isoforms I-XIV","volume":"22","author":"Ceruso","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1021\/jm5012935","article-title":"Structural insights into carbonic anhydrase IX isoform specificity of carbohydrate-based sulfamates","volume":"57","author":"Moeker","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.matbio.2015.01.019","article-title":"Moving targets: Emerging roles for MMPs in cancer progression and metastasis","volume":"44\u201346","author":"Shay","year":"2015","journal-title":"Matrix Biol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/17460441.2018.1398732","article-title":"Recent opportunities in matrix metalloproteinase inhibitor drug design for cancer","volume":"13","author":"Zhong","year":"2018","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrm3904","article-title":"Remodelling the extracellular matrix in development and disease","volume":"15","author":"Bonnans","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jnci\/93.3.178","article-title":"Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy","volume":"93","author":"Hidalgo","year":"2001","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1021\/jm000027t","article-title":"Carbonic anhydrase and matrix metalloproteinase inhibitors: Sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes","volume":"43","author":"Scozzafava","year":"2000","journal-title":"J. Med. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.bmc.2007.01.023","article-title":"Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates","volume":"15","author":"Nuti","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/14756366.2013.879656","article-title":"Synthesis and biological activity of novel thiourea derivatives as carbonic anhydrase inhibitors","volume":"30","author":"Korkmaz","year":"2015","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1016\/j.bmc.2015.07.066","article-title":"Exploring new Probenecid-based carbonic anhydrase inhibitors: Synthesis, biological evaluation and docking studies","volume":"23","author":"Mollica","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1016\/j.bmc.2015.10.009","article-title":"Carbonic anhydrase inhibitors: Design, synthesis, kinetic, docking and molecular dynamics analysis of novel glycine and phenylalanine sulfonamide derivatives","volume":"23","author":"Fidan","year":"2015","journal-title":"Bioorg. Med. Chem."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/8\/2\/36\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:05:49Z","timestamp":1760195149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/8\/2\/36"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,24]]},"references-count":79,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,6]]}},"alternative-id":["metabo8020036"],"URL":"https:\/\/doi.org\/10.3390\/metabo8020036","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints201805.0145.v1","asserted-by":"object"}]},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,24]]}}}